Social Media Is Fueling Enthusiasm for New Weight Loss Drugs. Are Regulators Watching?

Online platforms are overflowing with testimonials for GLP-1s. The drugs show promise for inducing weight loss, but many aren’t FDA-approved for that use.

Related Keywords

Georgetown University ,District Of Columbia ,United States ,Chicago ,Illinois ,Australia ,Washington ,New Jersey ,New York ,United Kingdom ,Americans ,Australian ,Chelsea Handler ,Juliana Simonetti ,Priya Jaisinghani ,Jeremy Kahn ,Elizabeth Wassenaar ,Allison Schneider ,Novo Nordisk Ozempic ,Novo Nordisk Wegovy ,Michael Albert ,Suzette Zuena ,Eli Lilly Mounjaro ,Remi Bader ,Judy Butler ,Samantha Klecyngier ,Georgetown University Medical Center ,Health Care Providers ,Morgan Stanley ,Health News ,University Of Utah ,Novo Nordisk ,Facebook ,Instagram ,York University Grossman School Of Medicine ,Recovery Center ,New York University ,Grossman School ,Eli Lilly ,California Healthline ,Federal Trade Commission ,Eating Recovery Center ,Compounding Spark Excitement ,Accomplish Health ,Health Care ,Weight Loss ,New York City ,